About us
The RWTH cBMB is the central Biomaterial Bank (cBMB) of the University Hospital of the RWTH Aachen – a maximum care hospital with 36 clinics and 28 institutes. cBMB collects and processes a wide variety of biospecimens such as blood, urine and tissue with the application of high-quality standards.
cBMB aims to support research projects focussing on oncological, cardiological and neurological diseases.
338,151 aliquots (as of September 1st, 2023) are currently stored in liquid nitrogen tanks or -80 °C freezers. cBMB's strict quality management system ensures optimal processes, from semi-automated sample processing through storage to reprocessing and output for research purposes, in compliance with all data protection guidelines. It is supported by a central biosample management system (CentraXX) as well as its own IT infrastructure. cBMB thus provides an ideal basis for close networking of the sample and data pool within the framework of the German Biobank Alliance (GBA).
Profile
Clinical Biobank, Tissue Biobank, Liquid Biobank
Accreditation and/or certification
In preparation
Testimonial
Participation in GBN activities in quality management
Round robin tests
Tissue RNA: 2019, 2020, 2022 Liquid DNA: 2018, 2020 PBMC: 2020 Processing and shipping of blood samples: 2023
Friendly audits
2019, 2020
Key figures (01.09.2023)
338,573
available liquid samples
20,573
available solid samples
403
projects initiated
2011
founded in
Funding bodies and partners
Contact
Uniklinik RWTH Aachen (AöR)
Centralised Biomaterial Bank of the RWTH Aachen University
Pauwelstraße 30
52074 Aachen
Univ.-Prof. Dr. rer. nat. Edgar Dahl
Scientific Director of the RWTH cBMB
Location
Observer
Partner
© 2024 All rights reserved.
